Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Leukemia Fusion Genes (Q30) Screening Kit
Connect with this vendor - Learn about this product

Leukemia Fusion Genes (Q30) Screening Kit

Leukemia Fusion Genes (Q30) Screening Kit 

Leukemia Fusion Genes (Q30) Screening Kit is a qualitative in vitro diagnostic test for screening of 30 fusion genes
resulted from chromosome translocations involved in chronic and acute leukemia. All the 30 fusion genes include more than
155 clinically relevant chromosomal breakpoints [1-9] . The kit detects RNA transcripts of fusion genes extracted from human
bone marrow or whole blood samples using a RT-qPCR procedure.

The fusion gene detected by the kit allows professionals to be more aware of the patient`s prognosis and provides
professionals important insights into the treatment planning.